Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a cloud and inquiry icon representing medical information management.

Aug 7, 2026

TikaMobile Launches MedInfosys, a Purpose-Built Medical Information Software Platform for Life Sciences

TikaMobile has introduced MedInfosys, a specialized software platform designed to streamline medical information management for life sciences organizations.This new cloud-based system consolidates inquiries from healthcare professionals (HCPs) into a single, compliant workflow, addressing the challenges faced by MedInfo teams in handling requests related to drug dosing, safety, and device indications. By integrating various communication channels—such as web forms, email, and phone—the platform
A tau protein sample viewed through a microscope in a lab setting.

Aug 6, 2026

Tau and Alzheimer’s Disease

Recent advancements in Alzheimer’s disease (AD) research highlight the critical role of tau protein in understanding and addressing the disease's progression.Over the past few decades, significant strides have been made in AD research, particularly in brain imaging, biomarker development, and immunotherapy. Despite these advancements, current treatments primarily slow cognitive decline rather than preventing it. Central to ongoing research is tau, a microtubule-associated protein that aggregates
A medical chart and pen on a wooden desk in a dimly lit office.

Aug 6, 2026

TikaMobile Launches MedInfosys, a Purpose-Built Medical Information Software Platform for Life Sciences

TikaMobile has unveiled MedInfosys, a specialized software platform designed to streamline medical information management for life sciences organizations.This new cloud-based system consolidates inquiries from healthcare professionals (HCPs) into a unified, compliant workflow. MedInfosys addresses the challenges of managing requests related to drug dosing, safety, and device indications, which often become scattered across various communication channels. By centralizing these inquiries, the plat
Press release cover image

Aug 6, 2026

Press release

Proscia Receives New FDA 510(k) Clearance for Concentriq AP-Dx with Predetermined Change Control Plan

Regulatory milestone advances Proscia’s open approach to digital pathologyPHILADELPHIA — August 6, 2026 — Proscia®has received a new 510(k) clearance from the U.S. Food and Drug Administration(FDA) for Concentriq® AP-Dx. The clearance includes compatibilitywith the Leica Aperio® GT 450 DX slide scanner, cloud deployment,and a Predetermined Change Control Plan (PCCP). Concentriq AP-Dx is a digitalpathology platform for primary diagnosis used by laboratories of all sizes. Through the PCCP, Proscia
Press release cover image

Aug 6, 2026

Press release

Caris Life Sciences, ECOG-ACRIN and NRG Oncology Study Demonstrates Multimodal AI Approach to Predict Late Distant Recurrence Risk in HR+ Early Breast Cancer

Findings published in Cancer Research Communications highlight potential to inform extended endocrine therapy decisionsIRVING, Texas, Aug. 6, 2026 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading TechBio company, today announced the publication of a study in Cancer Research Communications demonstrating the ability of a multimodal, multitask deep learning model to estimate late distant recurrence risk in hormone receptor-positive (HR+) early breast cancer.The study, titled "Development and
Press release cover image

Aug 6, 2026

Press release

OneOncology and OpenEvidence Partner to Improve Cancer Care Nationwide

MIAMI & NASHVILLE, Tenn.--(BUSINESS WIRE)--#Oncology--OpenEvidence, the most widely used AI-powered medical search and clinical decision-support platform, and OneOncology, a physician-led national platform empowering independent medical specialty practices, today announced a partnership to embed OpenEvidence into certain clinical applications used across OneOncology’s platform to enable physicians to use OpenEvidence for clinical evidence retrieval, reference and research. The integration is
Press release cover image

Aug 6, 2026

Press release

Philips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedside

August 6, 2026 New collaborations expand wearable and out-of-hospital monitoring capabilities, helping support continuous patient visibility from admission through recovery at home  Amsterdam, Netherlands. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree and smartQare, further expanding its open monitoring ecosystem. The collaborations help health system
Press release cover image

Aug 6, 2026

Press release

Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform

HOUSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), announced today that it has selected XiFin, Inc. (“XiFin”), a market leader in artificial intelligence (AI)-driven revenue cycle management (RCM) for diagnostic providers, to provide billing and clearinghouse services for the CNSide® Cerebrospinal Fluid (CSF) Assay Platform. The Company expects to commence billing through the XiFin platfo
Press release cover image

Aug 6, 2026

Press release

Shape Therapeutics and Rett Syndrome Research Trust Announce Partnership to Advance a One-Time AI-Designed RNA Editing Therapy for Rett Syndrome

Collaboration will evaluate Shape's intravenously delivered RNAfix® gene therapy designed to correct the MECP2 R168X mutation in non-human primates (NHP) SEATTLE, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA editing-based gene therapy, today announced a partnership with the Rett Syndrome Research Trust (RSRT) to advance SHP-401, an investigational one-time gene therapy for Rett syndrome. Under the agreement, RSRT will fund translational studies to evaluate Shape’s RNAf
A minimalist representation of a drug molecule in a dark color scheme.

Aug 6, 2026

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

Clarivate has announced the enhancement of its agentic AI capabilities within the Cortellis portfolio, aimed at streamlining drug development processes for life sciences organizations.This expansion allows research and development teams to leverage AI to accelerate discovery, improve safety assessments, and make informed decisions throughout the drug development lifecycle. By integrating AI into existing workflows, researchers can minimize manual tasks and concentrate on strategic scientific dec
Minimalist illustration of an AI brain above a cloud

Aug 6, 2026

Microsoft's Medical AI Expansion Fueled by OpenAI, Which Drives Over Half of Revenue — Platform War Intensifies

Microsoft's recent disclosures reveal that its medical AI expansion is significantly driven by OpenAI, which contributes over half of its AI revenue, intensifying competition in the healthcare technology sector.New regulatory filings indicate that Microsoft generated approximately $24.1 billion from OpenAI in its 2026 fiscal year, highlighting a heavy reliance on OpenAI for its AI initiatives. This revenue accounts for over 70% of Microsoft's AI business, underscoring the critical role OpenAI pl
Press release cover image

Aug 6, 2026

Press release

GenScript and Tamarind Bio Partner to Connect AI Molecular Design with Rapid Lab Validation

Collaboration combines Tamarind Bio's AI-powered molecular design platform with GenScript's wet-lab capabilities to help researchers move from digital concepts to experimental proofPISCATAWAY, N.J. and SAN FRANCISCO, Aug. 5, 2026 /PRNewswire/ -- Artificial intelligence can now generate thousands of potential drug molecules in the time it once took to design one, dramatically expanding what scientists can imagine. Yet deciding which designs merit further investment still depends on experimental p